BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2572001)

  • 1. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
    Asin KE; Montana WE
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1033-41. PubMed ID: 2572001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):1-8. PubMed ID: 2908061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C; Chase TN
    Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1991; 105(1):107-12. PubMed ID: 1684056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1989 Jun; 33(2):273-9. PubMed ID: 2573075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE; Sutherland JV; Woolverton WL
    Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.
    Nunes JL; Sharif NA; Michel AD; Whiting RL
    Neurochem Res; 1991 Oct; 16(10):1167-74. PubMed ID: 1686637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.
    Asin KE; Montana WE
    Pharmacol Biochem Behav; 1988 Jan; 29(1):89-92. PubMed ID: 3258427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
    Ellenbroek BA; Artz MT; Cools AR
    Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ; Franklin KB
    Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptors and sensorimotor behavior in MPTP-treated mice.
    Weihmuller FB; Hadjiconstantinou M; Bruno JP
    Behav Brain Res; 1990 May; 38(3):263-73. PubMed ID: 1973042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
    Asin KE; Bednarz LM
    Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.